At a glance
- Originator Mochida Pharmaceutical
- Class Antithrombotics
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thromboembolism; Thrombosis
Most Recent Events
- 05 Apr 2001 New profile
- 05 Apr 2001 Preclinical development for Thromboembolism in Japan (PO)
- 05 Apr 2001 Preclinical development for Thrombosis in Japan (PO)